Treatment and diagnostics ankylosing spondylitis (bechterew’s disease) in Munich, Germany

Treatment of ankylosing spondylitis in Munich is a combined program that helps reduce inflammation in the joints and spine, relieve chronic pain, and restore the usual range of trunk movements. Ankylosing spondyloarthritis may develop for many reasons — enterobacterial infection, endocrine dysfunction, prolonged arthritis, rheumatism, and a genetic factor. To achieve a stable therapeutic effect, it is desirable to act on the causes of the disease.

The primary goal of treatment of ankylosing spondylitis in Munich is to neutralize inflammation and pain. Additional goals include restoring mobility, counteracting chest stiffness, and protecting against future complications.

Diagnosis of ankylosing spondyloarthritis is carried out by the following methods:

• laboratory blood tests (C-reactive protein, rheumatoid factor, biochemistry, fibrinogen, etc.),
• standard and stress ECG,
• MRI of the spine,
• ultrasound of the soft tissues of the back,
• ultrasound and Doppler studies of the kidneys and renal arteries,
• plain and targeted radiography.

The following means are used in therapy of ankylosing spondylitis:

• new-generation pharmacological drugs (NSAIDs, biologic modifiers, DMARDs, painkillers),
• physiotherapy,
• spa procedures (balneotherapy, mud therapy, etc.),
• breathing exercises,
• therapeutic exercise,
• diet therapy,
• preventive therapy.

In severe and advanced cases, when the joints are significantly destroyed, joint replacement surgery is used. It is performed with minimally invasive methods through tiny punctures, which helps reduce trauma, speed tissue regeneration, and protect the patient from unwanted complications.

Postoperative recovery takes place under medical supervision in a hospital. If desired, the patient may undergo rehabilitation at home using the recommendations of the attending doctor.